Albuminuria and tubular atrophy are also risk factors for the progression of CKD to ESRD, and kidney proximal tubule lipoapoptosis is caused by dysregulation of fatty acid transporter-2 (FATP2), which may be an appropriate molecular target for the treatment of CKD [43]. This evidence concerns the gene SLC27A2 and chronic kidney disease.